170 related articles for article (PubMed ID: 11711527)
1. Biochemical assessment of myocardial fibrosis in hypertensive heart disease.
López B; González A; Varo N; Laviades C; Querejeta R; Díez J
Hypertension; 2001 Nov; 38(5):1222-6. PubMed ID: 11711527
[TBL] [Abstract][Full Text] [Related]
2. The use of collagen-derived serum peptides for the clinical assessment of hypertensive heart disease.
López B; González A; Querejeta R; Díez J
J Hypertens; 2005 Aug; 23(8):1445-51. PubMed ID: 16003166
[TBL] [Abstract][Full Text] [Related]
3. Toward the biochemical assessment of myocardial fibrosis in hypertensive patients.
Díez J; Laviades C; Monreal I; Gil MJ; Panizo A; Pardo J
Am J Cardiol; 1995 Nov; 76(13):14D-17D. PubMed ID: 7495211
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients.
López B; Querejeta R; Varo N; González A; Larman M; Martínez Ubago JL; Díez J
Circulation; 2001 Jul; 104(3):286-91. PubMed ID: 11457746
[TBL] [Abstract][Full Text] [Related]
5. Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome.
Ravassa S; López B; Querejeta R; Echegaray K; San José G; Moreno MU; Beaumont FJ; González A; Díez J
J Hypertens; 2017 Apr; 35(4):853-861. PubMed ID: 28253222
[TBL] [Abstract][Full Text] [Related]
6. Serum markers of collagen type I metabolism in spontaneously hypertensive rats: relation to myocardial fibrosis.
Díez J; Panizo A; Gil MJ; Monreal I; Hernández M; Pardo Mindán J
Circulation; 1996 Mar; 93(5):1026-32. PubMed ID: 8598066
[TBL] [Abstract][Full Text] [Related]
7. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations.
Díez J; Laviades C; Mayor G; Gil MJ; Monreal I
Circulation; 1995 Mar; 91(5):1450-6. PubMed ID: 7867186
[TBL] [Abstract][Full Text] [Related]
8. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis.
Querejeta R; López B; González A; Sánchez E; Larman M; Martínez Ubago JL; Díez J
Circulation; 2004 Sep; 110(10):1263-8. PubMed ID: 15313958
[TBL] [Abstract][Full Text] [Related]
9. Treatment of congestive heart failure: interfering the aldosterone-cardiac extracellular matrix relationship.
Zannad F; Dousset B; Alla F
Hypertension; 2001 Nov; 38(5):1227-32. PubMed ID: 11711528
[TBL] [Abstract][Full Text] [Related]
10. TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension.
Lindsay MM; Maxwell P; Dunn FG
Hypertension; 2002 Aug; 40(2):136-41. PubMed ID: 12154103
[TBL] [Abstract][Full Text] [Related]
11. Galectin-3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin.
López B; González A; Querejeta R; Zubillaga E; Larman M; Díez J
Eur J Heart Fail; 2015 Apr; 17(4):385-92. PubMed ID: 25684565
[TBL] [Abstract][Full Text] [Related]
12. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease.
Querejeta R; Varo N; López B; Larman M; Artiñano E; Etayo JC; Martínez Ubago JL; Gutierrez-Stampa M; Emparanza JI; Gil MJ; Monreal I; Mindán JP; Díez J
Circulation; 2000 Apr; 101(14):1729-35. PubMed ID: 10758057
[TBL] [Abstract][Full Text] [Related]
13. Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats.
Varo N; Etayo JC; Zalba G; Beaumont J; Iraburu MJ; Montiel C; Gil MJ; Monreal I; Díez J
J Hypertens; 1999 Jan; 17(1):107-14. PubMed ID: 10100101
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta in hypertensives with cardiorenal damage.
Laviades C; Varo N; Díez J
Hypertension; 2000 Oct; 36(4):517-22. PubMed ID: 11040229
[TBL] [Abstract][Full Text] [Related]
15. Procollagen type III amino terminal peptide and myocardial fibrosis: A study in hypertensive patients with and without left ventricular hypertrophy.
dos Santos Moreira C; Serejo F; Alcântara P; Ramalhinho V; Braz Nogueira J
Rev Port Cardiol; 2015 May; 34(5):309-14. PubMed ID: 25958256
[TBL] [Abstract][Full Text] [Related]
16. [Biochemical diagnosis of hypertensive myocardial fibrosis].
Díez J; Laviades C; Varo N; Querejeta R; López B
Rev Esp Cardiol; 2000; 53 Suppl 1():8-13. PubMed ID: 11007663
[TBL] [Abstract][Full Text] [Related]
17. Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: potential role of altered collagen metabolism.
Huerta A; López B; Ravassa S; San José G; Querejeta R; Beloqui Ó; Zubillaga E; Rábago G; Brugnolaro C; Díez J; González A
J Hypertens; 2016 Jan; 34(1):130-8. PubMed ID: 26575701
[TBL] [Abstract][Full Text] [Related]
18. Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy.
Krum H; Elsik M; Schneider HG; Ptaszynska A; Black M; Carson PE; Komajda M; Massie BM; McKelvie RS; McMurray JJ; Zile MR; Anand IS
Circ Heart Fail; 2011 Sep; 4(5):561-8. PubMed ID: 21750125
[TBL] [Abstract][Full Text] [Related]
19. [Left ventricular mass, diastolic function and collagen metabolism biomarkers in essential hypertension].
Macías Blanco C; Fatela-Cantillo D; Jiménez-Jiménez L; López Aguilar R; Moreno-Luna R; Doblas Delgado A; Stiefel P
Med Clin (Barc); 2012 Feb; 138(4):139-44. PubMed ID: 21939991
[TBL] [Abstract][Full Text] [Related]
20. Circulating collagen metabolites, myocardial fibrosis and heart failure in aortic valve stenosis.
Kupari M; Laine M; Turto H; Lommi J; Werkkala K
J Heart Valve Dis; 2013 Mar; 22(2):166-76. PubMed ID: 23798204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
